Long-term maintenance of functional primary human hepatocytes using small molecules

Takeshi Katsuda, Masaki Kawamata, Ayako Inoue, Tomoko Yamaguchi, Maki Abe, Takahiro Ochiya

Research output: Contribution to journalArticle

Abstract

The immediate deterioration of primary human hepatocytes (PHHs) during culture limits their utility in drug discovery studies. Here, we report that a cocktail of four small molecule signaling inhibitors, termed YPAC, is useful for maintaining various hepatic functions of PHHs, including albumin and urea productivity, glycogen storage, and cytochrome P450 (CYP) expression. Most importantly, we found that YPAC allows PHHs to retain enzymatic activities of CYP1A2, CYP2B6, and CYP3A4 even after 40 days of culture, and that inducibility of CYP3A4 activity in response to the prototypical inducers rifampicin and phenobarbital is also maintained. Our novel approach could facilitate drug discovery studies.

Original languageEnglish
JournalFEBS Letters
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Cytochrome P-450 CYP3A
Hepatocytes
Drug Discovery
Molecules
Cytochrome P-450 CYP1A2
Rifampin
Phenobarbital
Glycogen
Cytochrome P-450 Enzyme System
Deterioration
Urea
Albumins
Productivity
Liver
Cytochrome P-450 CYP2B6

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Long-term maintenance of functional primary human hepatocytes using small molecules. / Katsuda, Takeshi; Kawamata, Masaki; Inoue, Ayako; Yamaguchi, Tomoko; Abe, Maki; Ochiya, Takahiro.

In: FEBS Letters, 01.01.2019.

Research output: Contribution to journalArticle

Katsuda, Takeshi ; Kawamata, Masaki ; Inoue, Ayako ; Yamaguchi, Tomoko ; Abe, Maki ; Ochiya, Takahiro. / Long-term maintenance of functional primary human hepatocytes using small molecules. In: FEBS Letters. 2019.
@article{f5b10ccf5d944d77a26fdd3791fa1f65,
title = "Long-term maintenance of functional primary human hepatocytes using small molecules",
abstract = "The immediate deterioration of primary human hepatocytes (PHHs) during culture limits their utility in drug discovery studies. Here, we report that a cocktail of four small molecule signaling inhibitors, termed YPAC, is useful for maintaining various hepatic functions of PHHs, including albumin and urea productivity, glycogen storage, and cytochrome P450 (CYP) expression. Most importantly, we found that YPAC allows PHHs to retain enzymatic activities of CYP1A2, CYP2B6, and CYP3A4 even after 40 days of culture, and that inducibility of CYP3A4 activity in response to the prototypical inducers rifampicin and phenobarbital is also maintained. Our novel approach could facilitate drug discovery studies.",
author = "Takeshi Katsuda and Masaki Kawamata and Ayako Inoue and Tomoko Yamaguchi and Maki Abe and Takahiro Ochiya",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/1873-3468.13582",
language = "English",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",

}

TY - JOUR

T1 - Long-term maintenance of functional primary human hepatocytes using small molecules

AU - Katsuda, Takeshi

AU - Kawamata, Masaki

AU - Inoue, Ayako

AU - Yamaguchi, Tomoko

AU - Abe, Maki

AU - Ochiya, Takahiro

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The immediate deterioration of primary human hepatocytes (PHHs) during culture limits their utility in drug discovery studies. Here, we report that a cocktail of four small molecule signaling inhibitors, termed YPAC, is useful for maintaining various hepatic functions of PHHs, including albumin and urea productivity, glycogen storage, and cytochrome P450 (CYP) expression. Most importantly, we found that YPAC allows PHHs to retain enzymatic activities of CYP1A2, CYP2B6, and CYP3A4 even after 40 days of culture, and that inducibility of CYP3A4 activity in response to the prototypical inducers rifampicin and phenobarbital is also maintained. Our novel approach could facilitate drug discovery studies.

AB - The immediate deterioration of primary human hepatocytes (PHHs) during culture limits their utility in drug discovery studies. Here, we report that a cocktail of four small molecule signaling inhibitors, termed YPAC, is useful for maintaining various hepatic functions of PHHs, including albumin and urea productivity, glycogen storage, and cytochrome P450 (CYP) expression. Most importantly, we found that YPAC allows PHHs to retain enzymatic activities of CYP1A2, CYP2B6, and CYP3A4 even after 40 days of culture, and that inducibility of CYP3A4 activity in response to the prototypical inducers rifampicin and phenobarbital is also maintained. Our novel approach could facilitate drug discovery studies.

UR - http://www.scopus.com/inward/record.url?scp=85071626927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071626927&partnerID=8YFLogxK

U2 - 10.1002/1873-3468.13582

DO - 10.1002/1873-3468.13582

M3 - Article

C2 - 31432507

AN - SCOPUS:85071626927

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

ER -